FDA Approved: NIZORAL — Supplemental Application (Kramer Laboratories)

View source ↗

Summary

FDA approved a supplemental application for NIZORAL (ketoconazole) from Kramer Laboratories, resulting in labeling updates for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidiasis
• Seborrheic Dermatitis
• Tinea Corporis
• Tinea Cruris
• Tinea Pedis
• Tinea Versicolor

Drugs mentioned

• NIZORAL (Ketoconazole)

Snippet

SUPPL AP for NIZORAL (KETOCONAZOLE)